Pear Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:PEAR   11:50:08 AM EDT
3.90
-0.12 (-2.98%)
Other Pre-Announcement

Pear Therapeutics Expects 2022 Revenue Of $22 Million

Published: 01/11/2022 22:16 GMT
Pear Therapeutics Inc - Ordinary Shares - Class A (PEAR) - Pear Therapeutics Inc - Sees 2022 Revenue of $22 Million.
Pear Therapeutics Inc - Sees 2023 Revenue of $125 Million.